 Source: ra2 studioShutterstock Last week, Global Blood Therapeutics NASDAQ: GBT stock was thrust into the spotlight on reports of a potential buyout bid from Pfizer NYSE: PFE . Today, though, Pfizer has officially disclosed that it will buy the company for 5.4 billion. 